Abingdon Health CEO Chris Yates Discusses London Listing and Growth Strategy | Chris Yates, CEO, Abingdon Health PLC. 00:10:00
Chris Yates, CEO of Abingdon Health PLC, reveals the company’s London listing debut aimed at accelerating growth. Yates emphasizes their commitment to supporting the UK government with their Covid-19 antibody test and outlines recent developments in manufacturing and launching these tests. Beyond Covid-19, Abingdon Health is expanding into animal health, infectious disease, oncology, and environmental testing.